Working with TipRanks
Follow Us
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
Adverum Biotechnologies (ADVM)
NASDAQ:ADVM
Adverum Biotechnologies (ADVM) Stock Price & Analysis
417 Followers
ADVM Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.53 - $2.34
Previous Close$0.94
Volume390.21K
Average Volume (3M)325.35K
Market Cap
$94.89M
Enterprise Value$44.59M
Total Cash (Recent Filing)$141.45M
Total Debt (Recent Filing)$91.15M
Price to Earnings (P/E)-0.7
Beta0.90
Next Earnings
Nov 09, 2023EPS Estimate
-$0.32Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.33
Shares Outstanding100,993,010
10 Day Avg. Volume291,062
30 Day Avg. Volume325,352
Standard Deviation0.26
R-Squared0.03
Alpha0.00372
Financial Highlights & Ratios
Price to Book (P/B)0.68
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-1.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue12.39
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-0.36
Forecast
1Y Price Target
$4.33Price Target Upside328.71% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering3
Adverum Biotechnologies News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
ADVM FAQ
What was Adverum Biotechnologies’s price range in the past 12 months?
Adverum Biotechnologies lowest stock price was $0.53 and its highest was $2.34 in the past 12 months.
What is Adverum Biotechnologies’s market cap?
Currently, no data Available
When is Adverum Biotechnologies’s upcoming earnings report date?
Adverum Biotechnologies’s upcoming earnings report date is Nov 09, 2023 which is in 22 days.
How were Adverum Biotechnologies’s earnings last quarter?
Adverum Biotechnologies released its earnings results on Aug 10, 2023. The company reported -$0.31 earnings per share for the quarter, beating the consensus estimate of -$0.329 by $0.019.
Is Adverum Biotechnologies overvalued?
According to Wall Street analysts Adverum Biotechnologies’s price is currently Undervalued.
Does Adverum Biotechnologies pay dividends?
Adverum Biotechnologies does not currently pay dividends.
What is Adverum Biotechnologies’s EPS estimate?
Adverum Biotechnologies’s EPS estimate is -$0.32.
How many shares outstanding does Adverum Biotechnologies have?
Adverum Biotechnologies has 100,993,010 shares outstanding.
What happened to Adverum Biotechnologies’s price movement after its last earnings report?
Adverum Biotechnologies reported an EPS of -$0.31 in its last earnings report, beating expectations of -$0.329. Following the earnings report the stock price went up 3.279%.
Which hedge fund is a major shareholder of Adverum Biotechnologies?
Among the largest hedge funds holding Adverum Biotechnologies’s share is Versant Venture Management, LLC. It holds Adverum Biotechnologies’s shares valued at 8M.
---
Adverum Biotechnologies Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$4.33 (328.71% Upside)
$4.33 (328.71% Upside)
Insider Transactions
Sold Shares
Worth $200.2 over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 0.9%
Last 30 Days ▼ 7.4%
Last 30 Days ▼ 7.4%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-0.21%
12-Months-Change
Fundamentals
Return on Equity
-71.11%
Trailing 12-Months
Asset Growth
-35.61%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Adverum Biotechnologies
Adverum Biotechnologies, Inc. is a clinical-stage biotechnology company that engages in the development of novel gene therapies to treat patients with sight-threatening ophthalmic diseases. It focuses on treatment of wet age-related macular degeneration, alpha-1 antitrypsin deficiency, hereditary angioedema, friedreich's ataxia, severe allergy, color vision deficiency, and juvenile x-linked retinoschisis. The company was founded by Mark S. Blumenkranz, Thomas W. Chalberg, Jr. and Steven Daniel Schwartz on July 17, 2006 and is headquartered in Menlo Park, CA.
---
Top 5 ETFs holding ADVM
Vanguard Total Stock Market ETF
$4.18M
Dimensional U.S. Core Equity 2 ETF
$6.63K
iShares Core S&P Total U.S. Stock Market ETF
$105.69
Xtrackers S&P 500 Swap UCITS ETF 5C-EUR Hedged
$15.84
Xtrackers S&P 500 Swap UCITS ETF
$15.84
Up to five ETFs with an Outperform Smart Score that hold ADVM. The ETFs are listed according to market value of ADVM within the ETF
---